READ OUR 2025 REPORT TO READERS

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

28.58 +0.61 (+2.18%)
Streaming Delayed Price Updated: 12:38 PM EST, Jan 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Fulgent Genetics, Inc.
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 200 companies hit new 52-week lows. 
Via Benzinga
News headline image
ROSEN, A TOP RANKED FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Reports Third Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Earnings Preview: Fulgent Genetics ↗
Fulgent Genetics (NASDAQ:FLGT) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Fulgent... 
Via Benzinga
News headline image
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Fulgent Genetics to Participate in Credit Suisse’s 31st Annual Healthcare Conference
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
A Look Into Healthcare Sector Value Stocks ↗
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
News headline image
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Medtronic, Palantir, Fulgent, and Yatsen and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Fulgent Genetics to Announce Third Quarter 2022 Financial Results on Monday November 7, 2022
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
FLGT LOSS ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLGT
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
NASDAQ:FLGT Investor Notice: Lawsuit Alleges Securities Laws Violations by Fulgent Genetics, Inc. ↗
San Diego, CA -- (SBWIRE) -- 10/05/2022 -- An investor, who purchased shares of Fulgent Genetics, Inc. (NASDAQ:FLGT), filed a lawsuit over alleged violations of Federal Securities Laws by Fulgent... 
Via SBWire
News headline image
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
A Look Into Healthcare Sector Value Stocks ↗
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base... 
Via Benzinga
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article